Shukra Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹6.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 83.85 per cent from ₹39.13 crore. This corresponds to a year-on-year *(YoY) decline of 52.37 per cent.
Operating Profit
Operating Profit stands at ₹0.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 97.42 per cent from ₹27.13 crore. This corresponds to a year-on-year *(YoY) decline of 90.44 per cent.
PBDT
PBDT stands at ₹1.39 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 94.97 per cent from ₹27.66 crore. This corresponds to a year-on-year *(YoY) decline of 83.67 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.38 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 98.58 per cent from ₹26.82 crore. This corresponds to a year-on-year *(YoY) decline of 94.98 per cent.
Net Profit
Net Profit stands at ₹-1.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 108.45 per cent from ₹20.36 crore. This represents a 131.91 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Shukra Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Shukra Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Shukra Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Shukra Pharmaceuticals Ltd Financial Reports
Shukra Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Shukra Pharma. | 0.63% | 0.63% | 10.92% | 9.08% | -25.66% | 56.16% |
| Jagsonpal Pharma | -1.31% | 2.66% | -2.36% | 8.12% | 40.12% | -22.04% |
| Amrutanjan Healt | 0.65% | -2.86% | -4.61% | -11.47% | -11.28% | -22.67% |
| Fredun Pharma | -4.24% | -1.11% | -3.94% | 25.29% | 76.42% | 174.14% |
| Fermenta Biotec. | 0.79% | 5.51% | 24.49% | 41.98% | 43.17% | 20.18% |
| Syncom Formul. | -1.44% | -1.37% | -6.74% | -5.59% | 3.26% | -28.85% |
| Lincoln Pharma. | -0.28% | 0.68% | -6.93% | -13.46% | 30.84% | 7.09% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Dakshesh Shah
Executive Director : Payal Mehta
E D & Wholetime Director : Dhruvin Shah
E D & Wholetime Director : Sanskruti Patel
Independent Non Exe. Director : Pinki Nirmal Sagar
Independent Non Exe. Director : Sonal Deepalbhai Gandhi
Independent Non Exe. Director : Sarjeevan Singh
Independent Non Exe. Director : Jitendra shah
Executive Director / Whole Time Director / CFO : Anar Jayesh Patel
E D & Wholetime Director : SHITAL DAKSHESH SHAH
Independent Non Exe. Director : Ritu Kapoor
Company Secretary / Compliance Officer : Shivkant Dhakad